Literature DB >> 15328049

New lipid formulation of amphotericin B: spectral and microscopic analysis.

Malika Larabi1, Annette Gulik, Jean-Paul Dedieu, Philippe Legrand, Gillian Barratt, Monique Cheron.   

Abstract

UV-visible and dichroic spectrum analysis and electron microscopy have been used to characterize a new amphotericin B (AmB) lipid formulation prepared by a solvent displacement process. The composition was dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylglycerol (DMPG) in molar ratio DMPC/DMPG/AmB 7:3:5, a similar composition to that of Abelcet. Although the latter has a "ribbon-like" structure, our process gave a thin disc-like structure. Analysis of circular dichroism (CD) and UV-visible spectra of formulations containing different percentages of AmB revealed that a minimum of AmB self-association was observed with 7:3:5 molar ratio. Varying the lipid ratio (DMPC/DMPG) while maintaining the fixed ratio of AmB yielded similar results when DMPC was in excess (DMPC/DMPG from 10:0 to 6:4). However, when the ratio was between 5:5 to 3:7, AmB self-aggregation increased. For compositions rich in DMPG (2:8 and 0:10), inversion of the CD spectrum was observed. The influence of the lipid composition on the morphology of the complex was also evident in electron microscopy. DMPC/DMPG/AmB (10:0:5) gave large unfracturable lamellae. The presence of DMPG shortened the lamellae, which often appeared as disc-like structures. AmB content, the presence of DMPG and the preparation process all contribute to generating these original structures with particular CD spectra.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15328049     DOI: 10.1016/j.bbamem.2004.05.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Development of novel docetaxel phospholipid nanoparticles for intravenous administration: quality by design approach.

Authors:  Dharmendra K Yadav; Harish Pawar; Shrikant Wankhade; Sarasija Suresh
Journal:  AAPS PharmSciTech       Date:  2015-01-13       Impact factor: 3.246

2.  Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery.

Authors:  Alexan I Gomez; Maria F Acosta; Priya Muralidharan; Jason X-J Yuan; Stephen M Black; Don Hayes; Heidi M Mansour
Journal:  Pulm Pharmacol Ther       Date:  2020-10-31       Impact factor: 3.410

3.  Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.

Authors:  K K Nishi; M Antony; P V Mohanan; T V Anilkumar; P M Loiseau; A Jayakrishnan
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

Review 4.  Leishmaniasis in humans: drug or vaccine therapy?

Authors:  Masoud Ghorbani; Ramin Farhoudi
Journal:  Drug Des Devel Ther       Date:  2017-12-22       Impact factor: 4.162

Review 5.  Optimizing efficacy of Amphotericin B through nanomodification.

Authors:  Gillian Barratt; Stéphane Bretagne
Journal:  Int J Nanomedicine       Date:  2007
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.